Wird geladen...
Biodistribution and radiation dose estimates for (68)Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors
PURPOSE: Somatostatin receptor antagonists have shown promise for imaging neuroendocrine tumors (NETs) in preclinical studies, but clinical data is still very limited. In this study, we assess the feasibility of using the novel somatostatin antagonist (68)Ga-DOTA-JR11 for PET imaging of NETs. METHOD...
Gespeichert in:
| Veröffentlicht in: | Eur J Nucl Med Mol Imaging |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6447060/ https://ncbi.nlm.nih.gov/pubmed/30374529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4193-y |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|